Strategic report Corporate governance Financial statements Financial statements Notes to the Company financial statements continued For the year ended 31 December 2016 53.
Financial policies for risk management and their objectives continued A $500 million with a fair value of $495 million 4.25 per cent.
Eurobond due April 2020 with the rating of BB Ba1.
The proceeds were Liquidity risk used to refinance existing debt and to finance part of the cash consideration of West-Ward Columbus acquisition.
Less than one Two to five year years Total 2016 $m $m $m 54.
Other non-current liabilities Cash and cash equivalents 32 32 Accounts receivable 2 2 Co-development and earnout payment agreement Interest bearing loans and borrowings 24 702 726 In 2015 the liability mainly relates to the present value of future payments on a co-development and earnout agreement.
As part of this Other payables 4 4 agreement, milestone payments dependent on successful clinical development of defined products are received by the Group.
In return of receiving such milestone payments, the Group has agreed to pay the contracting party a certain percentage of future sales of those 6 702 696 products.
As at 31 December 2016 and 31 December 2015, the liability associated with these earnout payments was adjusted to reflect the present value of the expected future cash outflows and the difference is presented as a finance cost income.
Less than one Two to five year years Total During 2016, the total liability was transferred to sister company, however PLC still acts as guarantor for the performance of a number of 2015 $m $m $m its affiliates pursuant to various agreements.
Cash and cash equivalents 363 363 Accounts receivable 3 3 55.
Financial policies for risk management and their objectives Interest bearing loans and borrowings 20 567 587 Currency risk Other payables 2 2 Currency risks as defined by IFRS 7 arise on account of financial instruments being denominated in a currency that is not the 344 567 223 functional currency and being of a monetary nature.
The following table illustrates financial assets and liabilities for the Company in different currencies: The Company believes that, given the Groups operating cash flow during 2016, it has the ability to satisfy its liability commitments.
Staff costs $m $m $m $m Hikma Pharmaceuticals PLC currently has an average of twenty-one employees 2015: sixteen excluding Executive Directors : total British Pound 1 compensation paid to them amounted to $6 million 2015: $4 million of which salaries and bonuses compromise an amount of $5 million A sensitivity analysis based on a 10% movement in foreign exchange rates has no material impact on the Company results and Company 2015: $3 million the remaining balance of $1 million 2015: $1 million represents national insurance contributions.
The cost of sharestatement of changes in equity.
based payments and other benefits presented below.
Further details on how the Company manages the currency risk are given in Note 30.
Stock options Interest rate risk The details of the stock compensation scheme are provided in note 38.
As at 31 December 2016, the total number of options granted to As at 31 December As at 31 December employees of the Company under the stock compensation scheme during the life of the scheme was 2,560,000 2015: 2,560,000.
2016 2015 Fixed rate Floating rate Total Fixed rate Floating rate Total $m $m $m $m $m $m Financial liabilities Interest-bearing loans and borrowings 495 145 640 494 494 Financial assets Cash and cash equivalents 27 27 357 357 An interest rate sensitivity analysis assumes an instantaneous 100 basis point change in interest rates in all currencies from their levels at 31 December 2016, with all other variables held constant.
Based on the composition of the Company debt and cash portfolio as at 31 December 2016, a 1% increase in interest rates would result in an additional interest expense of $1 million being incurred per year 2015: $4 million of interest income incurred.
Annual Report 2016 207 198 Hikma Pharmaceuticals plc Annual Report 2016 199
